70+ Key Companies Advancing in Dry Age-Related Macular Degeneration Clinical Trial Therapeutic Space | DelveInsight
DelveInsight's 'Dry Age-Related Macular Degeneration Pipeline Insight 2025' report provides comprehensive global coverage of ...
Veterinary Vaccines Market to Hit US$13.33 Billion by 2029 with 6.1% CAGR | MarketsandMarkets
The global Veterinary Vaccines Market, valued at US$8.93 billion in 2023, is forecasted to grow at a robust CAGR of 6.1%, reaching US$9.39 billion ...
Psoriasis Drugs Market To Reach USD 52.34 Billion By 2033, Growing At A 11.50% CAGR
psoriasis drugs market is expected to expand significantly, growing from an estimated USD 19.65 billion in 2024 ...
Global Bovine Tuberculosis Diagnosis Market Increasing Size, Demand, Growth Rate, And Forecast 2033 - Emergen Research
VANCOUVER, BRITISH COLUMBIA, CANADA, January 19, 2025 /EINPresswire / -- The Bovine Tuberculosis (TB) Diagnosis market is expected to grow from USD 781.5 million in 2024 to USD 1.16 billion by 2033, ...
Boehringer provides update on iclepertin Phase III program in schizophrenia
Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with ...
Biotherapeutics Market Insights 2025, Analysis and Forecast to 2030: Insulin Demand Soars Amid Diabetes Epidemic, Sees $40 Billion Opportunity
Boehringer Ingelheim, Lonza, ProBioGen, AGC Biologics, Selexis, Merck, and RocheDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Biotherapeutics Global Market Insights 2025, Analysis and Forecast to ...
Kansas City Star14d
Logo Brands Partners With HONAV USA to Bring FIFA and Olympics Products to Market
The partnership will allow Logo Brands to represent over 500 product lines, including drinkware, outdoor furniture, chairs, blankets, and HONAV USA's exclusive Olympic pins. The joint product ...
Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics
Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of ...
Le Lézard15d
Verdiva Bio, a New Clinical-Stage Cardiometabolic Company, Launches with Over $410M in Series A Financing to Advance Next-Generation Therapies
Verdiva launches with an oversubscribed Series A financing of $411M, co-led by Forbion and General Atlantic, with additional participation from RA Capital Management, OrbiMed, Logos Capital ...
Pharmaceutical Technology15d
UK-based Verdiva launches with $410m and an oral GLP-1RA candidate
The company has secured $410m in an oversubscribed Series A funding round, co-led by Forbion and General Atlantic, with contributions from investors such as RA Capital Management, OrbiMed, Logos ...